MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 258-261

  Nunobiki, Osamu ^a   Ueda, Masatsugu ^b   Yamamoto, Michiko ^b   Toji, Eisaku ^b   Sato, Naomi ^c   Izuma, Shinji ^b   Okamoto, Yoshiaki ^b   Torii, Kiyo ^b   Noda, Sadamu ^b  

^a KOBE TOKIWA UNIVERSITY   (Japan)

^b Osaka Cancer Prevention and Detection Center   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Cervical carcinogenesis; HPV; MDM2; Polymorphism

Indexed keywords

PROTEIN MDM2;

ALLELE; ARTICLE; CANCER GRADING; CARCINOGENESIS; CARCINOMA CELL; CELL LINE; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; JAPANESE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ALLELES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MDM2; UTERINE CERVICAL NEOPLASMS;

EID: 77955554890     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.009     Document Type: Article

References (31)

1. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J. Natl Cancer Inst. 92 2000 690 698
2. M. Ueda, Y.C. Hung, and Y. Terai Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells Hum. Cell 16 2003 241 251
3. M. Ueda, E. Toji, and O. Nunobiki Germline polymorphism of cancer susceptibility genes in gynecologic cancer Hum. Cell 21 2008 95 104
4. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
5. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
6. D. Michael, and M. Oren The p53 and Mdm2 families in cancer Curr. Opin. Genet. Dev. 12 2002 53 59
7. U.M. Moll, and O. Petrenko The MDM2-p53 interaction Mol. Cancer Res. 1 2003 1001 1008
8. G.L. Bond, W. Hu, and E.E. Bond A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 2004 591 602
9. C. Menin, M.C. Scaini, and G.L. De Salvo Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status J. Natl Cancer Inst. 98 2006 285 288
10. N. Dharel, N. Kato, and R. Muroyama MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C Clin. Cancer Res. 12 2006 4867 4871
11. S.S. Lum, H.W. Chua, and H. Li MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population Carcinogenesis 29 2008 754 761
12. L.G. Buchynska, I.P. Nesina, and E.V. Kashuba Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia Exp. Oncol. 29 2007 287 294
13. N. Horree, P.J. van Diest, P. van der Groep, D.M. Sie-Go, and A.P. Heintz Progressive derailment of cell cycle regulators in endometrial carcinogenesis J. Clin. Pathol. 61 2008 36 42
14. V. Meissner Rde, R.N. Barbosa, J.V. Fernandes, T.M. Galvao, A.F. Galvao, and G.H. Oliveira No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil Cancer Detect. Prev. 31 2007 371 374
15. M. Ueda, M. Ueki, T. Yamada, Y. Okamoto, T. Maeda, O. Sugimoto, and Y. Otsuki Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1) Hum. Cell 2 1989 401 410
16. S. Taguchi Establishment and characterization of the human uterine cervical epidermoid cancer cell line Acta Obstet. Gynaecol. Jpn 33 1981 1180 1188
17. I. Ishiwata, S. Nozawa, K. Kiguchi, S. Kurihara, and H. Okumura Establishment of human uterine cervical cancer cell line and comparative studies between normal and malignant uterine cervical cells in vitro Acta Obstet. Gynaecol. Jpn 30 1978 731 738
18. S. Nozawa, Y. Udagawa, H. Ohta, S. Kurihara, and W.H. Fishman Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin β-subunit, and pregnancy-specific β1-glycoprotein phenotypes Cancer Res. 43 1983 1748 1760
19. A. Mitsuhashi, H. Tanaka, N. Tanaka, M. Sugita, H. Shirasawa, H. Tokita, and H. Eda Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix Gynecol. Oncol. 70 1998 339 347
20. H. Shirasawa, Y. Tomita, A. Fuse, T. Yamamoto, H. Tanzawa, S. Sekiya, H. Takamizawa, and B. Simizu Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line J. Gen. Virol. 70 1989 1913 1919
21. M. Ueda, R.M. Gemmill, J. West, R. Winn, M. Sugita, N. Tanaka, M. Ueki, and H.A. Drabkin Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas Br. J. Cancer 85 2001 64 68
22. H. Nagano, H. Yoshikawa, T. Kawana, H. Yokota, Y. Taketani, H. Igarashi, H. Yoshikura, and A. Iwamoto Association of multiple human papillomavirus types with vulvar neoplasias J. Obstet. Gynaecol. Res. 22 1996 1 8
23. H. Yoshikawa, T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers Jpn J. Cancer Res. 82 1991 524 531
24. D.A. Arvanitis, and D.A. Spandidos Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study Oncol. Rep. 204 2008 751 760
25. R. Cristina Mazon, T. Rovigatti Gerbelli, C. Benatti Neto, M.R. de Oliveira, E. Antonio Donadi, M.A. Guimaraes Goncalves, E. Garcia Soares, C. Patricia Klay, I. Tersariol, M. Aparecida Pinhal, and L. Resende Pienna Soares, C. Abnormal cell-cycle expression of the proteins p27, mdm2 and cathepsin B in oral squamous-cell carcinoma infected with human papillomavirus Acta Histochem. 2009 Oct 5 [Epub ahead of print]
26. R.D. Farhadieh, A. Salardini, C.G. Rees, P.J. Russell, J.L. Yang, and R. Smee Protein expression of epidermal growth factor receptor in laryngeal squamous cell carcinoma index tumors correlates with diagnosis of second primary tumors of the upper aero-digestive tract Ann. Surg. Oncol. 16 2009 2888 2894
27. T.H. Cheng, P.K. Hsu, A.F. Li, I.C. Hung, M.H. Huang, and H.S. Hsu Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma J. Cancer Res. Clin. Oncol. 135 2009 1577 1582
28. D.W. Cescon, P.A. Bradbury, K. Asomaning, J. Hopkins, R. Zhai, W. Zhou, Z. Wang, M. Kulke, L. Su, C. Ma, W. Xu, A.L. Marshall, R.S. Heist, J.C. Wain, T.J. Lynch Jr, D.C. Christiani, and G. Liu p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis Clin. Cancer Res. 15 2009 3103 3109
29. S.F. Huang, I.H. Chen, C.T. Liao, H.M. Wang, S.H. Liou, and L.L. Hsieh Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing Oral Oncol. 45 2009 16 22
30. K. Sayama, S. Yonehara, Y. Watanabe, and Y. Miki Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes J. Invest. Dermatol. 103 1994 330 334
31. D.N. Contreras, P.H. Krammer, R.K. Potkul, P. Bu, J.L. Rossi, A.M. Kaufmann, L. Gissmann, and L. Qiao Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes J. Immunother. 23 2000 67 74